新余国科(300722) - 2024 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2024 was ¥78,925,998.17, representing a 21.72% increase compared to ¥64,843,584.28 in the same period last year[5] - Net profit attributable to shareholders decreased by 38.44% to ¥8,119,126.56 from ¥13,188,602.55 year-on-year[5] - Basic and diluted earnings per share fell by 38.46% to ¥0.0352 from ¥0.0572 year-on-year[5] - Net profit for Q1 2024 was ¥8,119,126.56, a decrease of 38.5% from ¥13,188,602.55 in Q1 2023[17] - Operating profit for the period was ¥9,496,353.03, down 43.1% from ¥16,694,668.23 in the same period last year[17] - The company reported a total comprehensive income of ¥7,931,919.28, a decrease of 39.5% from ¥13,079,680.32 in Q1 2023[18] Cash Flow and Financial Position - The net cash flow from operating activities was negative at -¥22,357,571.39, a decline of 439.52% compared to ¥6,585,065.48 in the previous year[5] - The net cash flow from operating activities for Q1 2024 was -22,357,571.39, a decrease from 6,585,065.48 in Q1 2023, indicating a significant decline in operational performance[21] - Total cash inflow from operating activities was 62,501,070.75, while cash outflow was 84,858,642.14, resulting in a negative cash flow situation[21] - The cash flow from investment activities was -2,931,359.63, compared to -4,104,721.63 in the same period last year, showing a slight improvement[21] - Cash flow from financing activities resulted in a net outflow of -416,000.00, down from -815,157.68 in Q1 2023, indicating reduced financing costs[21] - The company experienced a net decrease in cash and cash equivalents of -25,704,931.02, contrasting with an increase of 1,665,186.17 in the previous year[21] - The ending balance of cash and cash equivalents was 175,038,507.89, a decrease from 157,811,262.60 in Q1 2023[21] Assets and Liabilities - Total assets increased by 2.87% to ¥786,611,269.34 from ¥764,654,294.64 at the end of the previous year[5] - Accounts receivable increased to CNY 170.72 million from CNY 139.57 million year-on-year, representing a growth of approximately 22.3%[13] - Inventory increased to CNY 132.82 million from CNY 104.54 million year-on-year, reflecting a growth of about 27%[14] - Total liabilities increased to ¥189,854,285.03, up from ¥177,105,291.49 in the previous year[17] - The total liabilities included accounts payable of CNY 64.93 million, up from CNY 38.85 million year-on-year[14] - The company reported a significant increase in accounts payable, which rose by 67.12% to ¥64,925,019.04 from ¥38,849,959.88[7] Research and Development - Research and development expenses rose by 33.42% to ¥8,073,795.99, up from ¥6,051,439.79 in the same period last year[8] - Research and development expenses rose to ¥8,073,795.99, an increase of 33.4% compared to ¥6,051,439.79 in Q1 2023[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,882[10] - The largest shareholder, Jiangxi Provincial Military Industry Holding Group Co., Ltd., holds 37.60% of the shares[10] - Total equity attributable to shareholders reached ¥595,962,366.19, compared to ¥586,567,177.75 in Q1 2023[17] Other Information - The company received government subsidies amounting to ¥870,297.82 during the reporting period[6] - The company has not disclosed any new product developments or market expansion strategies in this report[12] - The company has not yet adopted the new accounting standards for the current year, which may impact future financial reporting[22] - The first quarter report has not been audited, which may affect the reliability of the financial data presented[22]